KemPharm (KMPH) Files IND with U.S. FDA to Commence Human Trials of KP201/IR
Tweet Send to a Friend
KemPharm, Inc. (Nasdaq: KMPH) announced that it has filed an Investigational New Drug (IND) application with the U.S. Food and ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
